Search

everythinglearnresearchcommunity

for

Search:↓

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Herbal hair care is beneficial and should be integrated into modern routines for healthier hair.

G-1 promotes hair growth in female mice by activating specific signaling pathways.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Managing inflammation and using vitamins can improve PRP therapy for better hair growth.

Valproic acid is effective but often causes side effects like weight gain and hair loss, so personalized treatment is needed.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Medications can cause eye problems, so regular eye check-ups are important.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Dandruff is a common, winter-worsened scalp condition linked to inflammation and microorganisms, treatable with products like ketoconazole, and may affect hair loss.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Skin reactions to antidepressants are common but usually not serious and can be treated.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Chitosan and surface-deacetylated chitin nanofibers may help treat hair loss.